Histology Tips & Tricks: Questions and Answers
Histology/ IHC is a multi-step process in which section and staining quality can be affected by a multitude of factors. Customers had specific questions for Leica Biosystems about common issues encountered that are addressed here.
1.How do you better ensure appropriate fixation and processing times for samples?
Tissue type, size and grossing methods will in part determine appropriate fixing time. Therefore, tissue processing should be optimized for each sample type.
Gross tissue should be of even thickness at no more than 3-4 mm to ensure sufficient fixation and reagent penetration.
Avoid overloading cassettes with tissue to ensure proper reagent flow through cassette and tissue.
Have adequate available fixing agent at 20:1 fixative-to-tissue ratio.
Cold fixation should be avoided. Room temperature or heated fixation allows for quicker penetration and fixation as the reaction is endothermic.
For manually prepared fixatives, confirm solution is at the appropriate concentration, optimal pH and limited exposure to oxidation.
2.Battle of the fixative: Things to consider
Alcohol: A dehydrant/ coagulant that destroys protein tertiary structure by displacing water, causing proteins to precipitate.
Formalin: An aldehyde that forms methylene bridge between proteins, forming covalent cross-links.
Coagulant fixatives are less toxic but can alter tissue morphology.
Cross-linking fixatives penetrate tissue quicker than alcohol but can distort or mask antigens for detection.
3.How to reduce nonspecific background IHC staining?
Adjust antibody concentration and incubation time to optimize sensitivity and specificity while balancing signal-to-noise ratio.
Consider switching from biotin-based detection to polymer-based detection for increased sensitivity without endogenous biotin background staining.
Quench for endogenous peroxidases if not already part of the staining protocol.
Increase time and/or concentration of blocking agent; if using animal serum, ensure there is no cross-reactivity.
Increasing washing steps between each stage of IHC staining protocol can reduce background further.
Ensure sections do not dry out during the IHC process to avoid air-drying artifacts.
4.How to get clearer tissue sections after staining?
For appropriate clearing of sections, optimize and ensure sufficient time and changes of: Ascending alcohol concentrations for dehydration. The final alcohol container should not have any water present and Clearing agent (e.g. xylene/ xylene substitute.). Confirm there is no water contamination in these reagents, and it should not have any alcohol present.
Avoid drying out of tissue sections to prevent introduction of air-drying artifact.
Confirm compatibility of the stain with dehydrant, clearing agent and mountant, as well as the mountant with clearing agent.
Ensure mountant is free of crystalline structures.
5. Most common fixative & its optimal pH?
About the presenter
Rhian is a Scientist from Swansea University in Medical and Healthcare Studies and was featured in several collaborative publications. Rhian’s research-based background focused on tissue-based pathology in Multiple Sclerosis, primarily using immunohistochemical analysis and in vitro molecular techniques. She spent a short period conducting routine PCR testing for COVID-19 at the end of 2020.
Related Content
Die Inhalte des Knowledge Pathway von Leica Biosystems unterliegen den Nutzungsbedingungen der Website von Leica Biosystems, die hier eingesehen werden können: Rechtlicher Hinweis. Der Inhalt, einschließlich der Webinare, Schulungspräsentationen und ähnlicher Materialien, soll allgemeine Informationen zu bestimmten Themen liefern, die für medizinische Fachkräfte von Interesse sind. Er soll explizit nicht der medizinischen, behördlichen oder rechtlichen Beratung dienen und kann diese auch nicht ersetzen. Die Ansichten und Meinungen, die in Inhalten Dritter zum Ausdruck gebracht werden, spiegeln die persönlichen Auffassungen der Sprecher/Autoren wider und decken sich nicht notwendigerweise mit denen von Leica Biosystems, seinen Mitarbeitern oder Vertretern. Jegliche in den Inhalten enthaltene Links, die auf Quellen oder Inhalte Dritter verweisen, werden lediglich aus Gründen Ihrer Annehmlichkeit zur Verfügung gestellt.
Vor dem Gebrauch sollten die Produktinformationen, Beilagen und Bedienungsanleitungen der jeweiligen Medikamente und Geräte konsultiert werden.
Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.